Grifols, S.A. Revenue 2012-2024 | GRFS

Grifols, S.A. annual/quarterly revenue history and growth rate from 2012 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Grifols, S.A. revenue for the quarter ending September 30, 2024 was $1.972B, a 20.07% increase year-over-year.
  • Grifols, S.A. revenue for the twelve months ending September 30, 2024 was $7.419B, a 23.59% increase year-over-year.
  • Grifols, S.A. annual revenue for 2023 was $7.134B, a 11.67% increase from 2022.
  • Grifols, S.A. annual revenue for 2022 was $6.389B, a 9.47% increase from 2021.
  • Grifols, S.A. annual revenue for 2021 was $5.836B, a 4.32% decline from 2020.
Grifols, S.A. Annual Revenue
(Millions of US $)
2023 $7,134
2022 $6,389
2021 $5,836
2020 $6,100
2019 $5,711
2018 $5,299
2017 $4,881
2016 $4,482
2015 $4,369
2014 $4,460
2013 $3,642
2012 $3,371
2011 $2,501
Grifols, S.A. Quarterly Revenue
(Millions of US $)
2024-09-30 $1,972
2024-06-30 $1,958
2023-06-30 $1,814
2023-03-31 $1,676
2022-06-30 $1,642
2021-06-30 $1,629
2019-06-30 $1,424
2018-06-30 $1,308
2017-06-30 $1,244
2017-03-31 $1,131
2016-12-31 $1,186
2016-09-30 $1,116
2016-06-30 $1,121
2016-03-31 $1,058
2015-12-31 $1,166
2015-09-30 $1,081
2015-06-30 $1,097
2015-03-31 $1,023
2014-12-31 $1,041
2014-09-30 $1,098
2014-06-30 $1,086
2014-03-31 $1,111
2013-12-31 $923
2013-09-30 $882
2013-06-30 $925
2013-03-31 $903
2012-12-31 $851
2012-09-30 $804
2012-06-30 $835
2012-03-31 $863
2011-12-31 $796
2011-09-30 $807
Sector Industry Market Cap Revenue
Medical MED-DRUGS $5.122B $7.134B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) JP $83.888B 33.10
Zoetis Inc. (ZTS) US $71.853B 27.10
Takeda Pharmaceutical Co. (TAK) JP $44.737B 9.90
Daiichi Sankyo Co., Ltd. - Sponsored ADR (DSNKY) JP $43.224B 26.34
Sandoz Group AG Sponsored ADR (SDZNY) CH $20.442B 0.00
Merck KGaA (MKKGY) DE $18.230B 16.33
Astellas Pharma Inc. (ALPMY) JP $17.608B 12.47
Summit Therapeutics PLC (SMMT) US $16.312B 0.00
United Therapeutics Corporation (UTHR) US $16.121B 15.86
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) JP $12.709B 0.00
Neurocrine Biosciences, Inc. (NBIX) US $12.033B 36.68
Orion OYJ Unsponsored ADR (ORINY) FI $7.681B 21.59
Madrigal Pharmaceuticals, Inc. (MDGL) US $7.333B 0.00
Corcept Therapeutics Incorporated (CORT) US $6.657B 50.43
Stevanato Group S.p.A. (STVN) IT $6.329B 40.98
Hikma Pharmaceuticals Plc (HKMPF) GB $6.245B 0.00
Ionis Pharmaceuticals, Inc. (IONS) US $5.138B 0.00
Ono Pharmaceutical Co. (OPHLF) JP $4.650B 9.52
Recursion Pharmaceuticals, Inc. (RXRX) US $3.626B 0.00
Crinetics Pharmaceuticals, Inc. (CRNX) US $3.474B 0.00
Catalyst Pharmaceuticals, Inc. (CPRX) US $2.579B 11.69
AMNEAL PHARMACEUTICALS, INC. (AMRX) US $2.426B 14.50
Centessa Pharmaceuticals PLC Sponsored ADR (CNTA) GB $2.193B 0.00
Hypermarcas (HYPMY) BR $2.154B 0.00
Soleno Therapeutics, Inc. (SLNO) US $1.989B 0.00
BioCryst Pharmaceuticals, Inc. (BCRX) US $1.908B 0.00
NewAmsterdam Pharma Company N.V. (NAMS) NL $1.716B 0.00
Evotec AG (EVO) DE $1.573B 0.00
Dyne Therapeutics, Inc. (DYN) US $1.426B 0.00
Guardian Pharmacy Services, Inc. (GRDN) US $1.239B 0.00
Ardelyx, Inc. (ARDX) US $1.198B 0.00
Indivior PLC (INDV) US $1.165B 5.06
Aurinia Pharmaceuticals Inc (AUPH) CA $1.135B 0.00
Xencor, Inc. (XNCR) US $1.102B 0.00
Ocular Therapeutix, Inc. (OCUL) US $1.101B 0.00
ARS Pharmaceuticals, Inc. (SPRY) US $1.092B 0.00
Enliven Therapeutics, Inc. (ELVN) US $1.065B 0.00
Harrow, Inc. (HROW) US $1.031B 0.00
Collegium Pharmaceutical, Inc. (COLL) US $0.939B 5.13
Bioventus Inc. (BVS) US $0.812B 25.67
Avadel Pharmaceuticals PLC. (AVDL) IE $0.810B 0.00
Cronos Group Inc. (CRON) CA $0.754B 0.00
Relay Therapeutics, Inc. (RLAY) US $0.656B 0.00
Verve Therapeutics, Inc. (VERV) US $0.616B 0.00
USANA Health Sciences, Inc. (USNA) US $0.606B 11.23
Xeris Biopharma Holdings, Inc. (XERS) US $0.559B 0.00
Elite Pharmaceuticals Inc. (ELTP) US $0.521B 0.00
OmniAb, Inc. (OABI) US $0.515B 0.00
KalVista Pharmaceuticals, Inc. (KALV) US $0.496B 0.00
Savara Inc. (SVRA) US $0.462B 0.00
Theravance Biopharma, Inc. (TBPH) KY $0.458B 0.00
Altimmune, Inc. (ALT) US $0.457B 0.00
ProKidney Corp. (PROK) US $0.437B 0.00
Siga Technologies Inc. (SIGA) US $0.422B 4.92
Zevra Therapeutics, Inc. (ZVRA) US $0.410B 0.00
Organogenesis (ORGO) US $0.404B 0.00
Aldeyra Therapeutics, Inc. (ALDX) US $0.398B 0.00
Akebia Therapeutics, Inc. (AKBA) US $0.393B 0.00
Oruka Therapeutics, Inc. (ORKA) US $0.386B 0.00
CytoDyn Inc. (CYDY) US $0.368B 0.00
Esperion Therapeutics, Inc. (ESPR) US $0.359B 0.00
Rigel Pharmaceuticals, Inc. (RIGL) US $0.354B 143.50
Tourmaline Bio, Inc. (TRML) US $0.313B 0.00
Ironwood Pharmaceuticals, Inc. (IRWD) US $0.290B 0.00
Aquestive Therapeutics, Inc. (AQST) US $0.274B 0.00
Heron Therapeutics, Inc. (HRTX) US $0.263B 0.00
Avita Medical Inc. (RCEL) US $0.256B 0.00
Nature's Sunshine Products, Inc. (NATR) US $0.252B 14.98
Korro Bio, Inc. (KRRO) US $0.246B 0.00
Innate Pharma SA (IPHYF) FR $0.243B 0.00
Amylyx Pharmaceuticals, Inc. (AMLX) US $0.226B 0.00
Profound Medical (PROF) CA $0.225B 0.00
4D Molecular Therapeutics, Inc. (FDMT) US $0.215B 0.00
Inhibikase Therapeutics, Inc. (IKT) US $0.206B 0.00
Lyell Immunopharma, Inc. (LYEL) US $0.205B 0.00
Larimar Therapeutics, Inc. (LRMR) US $0.204B 0.00
MediWound Ltd. (MDWD) IL $0.191B 0.00
Nanobiotix S.A. Sponsored ADR (NBTX) FR $0.177B 0.00
Acrivon Therapeutics, Inc. (ACRV) US $0.172B 0.00
Nektar Therapeutics (NKTR) US $0.172B 0.00
Enanta Pharmaceuticals, Inc. (ENTA) US $0.171B 0.00
VAXART, INC. (VXRT) US $0.162B 0.00
Aclaris Therapeutics, Inc. (ACRS) US $0.160B 0.00
Silence Therapeutics PLC Sponsored ADR (SLN) GB $0.143B 0.00
Champions Oncology, Inc. (CSBR) US $0.141B 0.00
Inotiv, Inc. (NOTV) US $0.137B 0.00
Lexeo Therapeutics, Inc. (LXEO) US $0.129B 0.00
Procaps Group, S.A. (PROCF) LU $0.126B 0.00
Cassava Sciences, Inc. (SAVA) US $0.123B 0.00
electroCore, Inc. (ECOR) US $0.118B 0.00
Telomir Pharmaceuticals, Inc. (TELO) US $0.116B 0.00
Achieve Life Sciences, Inc. (ACHV) CA $0.109B 0.00
Journey Medical Corporation (DERM) US $0.108B 0.00
Corbus Pharmaceuticals Holdings, Inc. (CRBP) US $0.100B 0.00
Cardiol Therapeutics Inc. (CRDL) CA $0.099B 0.00
Galectin Therapeutics Inc. (GALT) US $0.094B 0.00
Arch Biopartners Inc. (ACHFF) CA $0.089B 0.00
Metagenomi, Inc. (MGX) US $0.088B 0.00
Avalo Therapeutics, Inc. (AVTX) US $0.088B 0.00
Regulus Therapeutics Inc. (RGLS) US $0.086B 0.00
Nutriband Inc. (NTRB) US $0.083B 0.00
Assertio Holdings, Inc. (ASRT) US $0.078B 20.32
Protara Therapeutics, Inc. (TARA) US $0.077B 0.00
ESSA Pharma Inc. (EPIX) CA $0.076B 0.00
Pyxis Oncology, Inc. (PYXS) US $0.076B 0.00
Karyopharm Therapeutics Inc. (KPTI) US $0.076B 0.00
Cumberland Pharmaceuticals Inc. (CPIX) US $0.075B 0.00
PMV Pharmaceuticals, Inc. (PMVP) US $0.073B 0.00
FibroGen, Inc (FGEN) US $0.071B 0.00
Mural Oncology PLC (MURA) IE $0.069B 0.00
Fractyl Health, Inc. (GUTS) US $0.068B 0.00
Vivani Medical, Inc. (VANI) US $0.068B 0.00
Unicycive Therapeutics, Inc. (UNCY) US $0.064B 0.00
Century Therapeutics, Inc. (IPSC) US $0.062B 0.00
AleAnna Inc. (ANNA) US $0.062B 0.00
Context Therapeutics Inc. (CNTX) US $0.061B 0.00
Gain Therapeutics, Inc. (GANX) US $0.060B 0.00
OptiNose, Inc. (OPTN) US $0.058B 0.00
Reviva Pharmaceuticals Holdings, Inc. (RVPH) US $0.053B 0.00
Dominari Holdings Inc. (DOMH) US $0.052B 0.00
Iterum Therapeutics PLC (ITRM) IE $0.052B 0.00
Rafael Holdings, Inc. (RFL) US $0.050B 0.00
AlloVir, Inc. (ALVR) US $0.049B 0.00
Prelude Therapeutics Incorporated (PRLD) US $0.048B 0.00
SCYNEXIS, Inc. (SCYX) US $0.041B 0.00
VYNE Therapeutics Inc. (VYNE) US $0.040B 0.00
NRx Pharmaceuticals, Inc. (NRXP) US $0.039B 0.00
CASI Pharmaceuticals Inc. (CASI) CN $0.038B 0.00
Tempest Therapeutics, Inc. (TPST) US $0.038B 0.00
Surrozen, Inc. (SRZN) US $0.036B 0.00
Verrica Pharmaceuticals Inc. (VRCA) US $0.034B 0.00
PolyPid Ltd. (PYPD) IL $0.030B 0.00
Incannex Healthcare Inc. (IXHL) AU $0.029B 0.00
Jupiter Neurosciences, Inc. (JUNS) US $0.028B 0.00
BioVie Inc. (BIVI) US $0.027B 0.00
Natural Alternatives International, Inc. (NAII) US $0.025B 0.00
DURECT Corporation (DRRX) US $0.025B 0.00
Scienture Holdings, Inc. (SCNX) US $0.024B 0.00
Enlivex Therapeutics Ltd. (ENLV) IL $0.021B 0.00
Mannatech, Incorporated (MTEX) US $0.021B 0.00
GlycoMimetics, Inc. (GLYC) US $0.019B 0.00
Carisma Therapeutics Inc. (CARM) US $0.019B 0.00
Vivos Therapeutics, Inc. (VVOS) US $0.018B 0.00
Lipocine Inc. (LPCN) US $0.018B 0.00
MEI Pharma, Inc. (MEIP) US $0.017B 0.00
Tonix Pharmaceuticals Holding Corp. (TNXP) US $0.017B 0.00
MARKER THERAPEUTICS, INC. (MRKR) US $0.017B 0.00
Traws Pharma, Inc. (TRAW) US $0.016B 0.00
Citius Pharmaceuticals, Inc. (CTXR) US $0.015B 0.00
Biomerica, Inc. (BMRA) US $0.015B 0.00
TherapeuticsMD, Inc. (TXMD) US $0.015B 0.00
Cosmos Health Inc. (COSM) US $0.014B 0.00
Lyra Therapeutics, Inc. (LYRA) US $0.013B 0.00
ProPhase Labs, Inc. (PRPH) US $0.013B 0.00
Minerva Neurosciences, Inc (NERV) US $0.013B 0.00
Nuvilex Inc. (PMCB) US $0.012B 0.00
BioLineRx Ltd. (BLRX) IL $0.012B 0.00
Phio Pharmaceuticals Corp. (PHIO) US $0.012B 0.00
Indaptus Therapeutics, Inc. (INDP) US $0.011B 0.00
Mangoceuticals, Inc. (MGRX) US $0.011B 0.00
Kiora Pharmaceuticals, Inc. (KPRX) US $0.010B 0.00
Klotho Neurosciences, Inc. (KLTO) US $0.010B 0.00
Talphera, Inc. (TLPH) US $0.010B 0.00
Jaguar Animal Health, Inc. (JAGX) US $0.010B 0.00
Relmada Therapeutics, Inc. (RLMD) US $0.009B 0.00
Ainos, Inc. (AIMD) US $0.009B 0.00
Addex Therapeutics Ltd. Sponsored ADR (ADXN) CH $0.008B 0.00
XTL Biopharmaceuticals Ltd. (XTLB) IL $0.008B 0.00
Plus Therapeutics, Inc. (PSTV) US $0.007B 0.00
NLS Pharmaceutics Ltd. (NLSP) CH $0.007B 0.00
Xenetic Biosciences, Inc. (XBIO) US $0.006B 0.00
Redhill Biopharma Ltd. (RDHL) IL $0.006B 0.00
Aptorum Group Limited (APM) GB $0.006B 0.00
TransCode Therapeutics Inc. (RNAZ) US $0.006B 0.00
Clearmind Medicine Inc. (CMND) CA $0.006B 0.00
CERo Therapeutics Holdings, Inc. (CERO) US $0.005B 0.00
SciSparc Ltd. (SPRC) IL $0.005B 0.00
Conduit Pharmaceuticals Inc. (CDT) US $0.004B 0.00
Sonoma Pharmaceuticals, Inc. (SNOA) US $0.004B 0.00
InMed Pharmaceuticals Inc. (INM) CA $0.004B 0.00
60 Degrees Pharmaceuticals Inc. (SXTP) US $0.003B 0.00
XORTX Therapeutics Inc. (XRTX) CA $0.003B 0.00
Avenue Therapeutics, Inc. (ATXI) US $0.003B 0.07
Alaunos Therapeutics, Inc. (TCRT) US $0.003B 0.00
Qualigen Therapeutics, Inc. (QLGN) US $0.003B 0.00
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) US $0.003B 0.00
SHINECO (SISI) CN $0.002B 0.00
Salarius Pharmaceuticals, Inc. (SLRX) US $0.002B 0.00
Galmed Pharmaceuticals Ltd. (GLMD) IL $0.002B 0.00
Heatwurx Inc. (PCSA) US $0.002B 0.00
Quoin Pharmaceuticals, Ltd. Sponsored ADR (QNRX) US $0.002B 0.00
Petros Pharmaceuticals, Inc. (PTPI) US $0.001B 0.00
China SXT Pharmaceuticals, Inc. (SXTC) CN $0.001B 0.00
TNF Pharmaceuticals, Inc. (TNFA) US $0.001B 0.00
Aditxt Inc. (ADTX) US $0.001B 0.00
PainReform Ltd. (PRFX) IL $0.000B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D pharma PLC Sponsored ADR (LBPS) GB $0.000B 0.00
Patheon N.V. (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals PLC (RVLP) US $0.000B 0.00